Anzeige
❌
Mehr »
Login
Montag, 23.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Die erste börsennotierte Gesellschaft, die auf das gemeinsame Wachstum von Solana, XRP und Dogecoin setzt!
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A3E2FW | ISIN: US87241J2033 | Ticker-Symbol: 0K30
Lang & Schwarz
22.12.24
16:00 Uhr
1,700 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TFF PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
TFF PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,5501,85022.12.

Aktuelle News zur TFF PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.12.TFF Pharmaceuticals, Inc. - 8-K, Current Report1SEC Filings
TFF PHARMACEUTICALS Aktie jetzt für 0€ handeln
20.11.TFF Pharmaceuticals, Inc. - 10-Q, Quarterly Report-SEC Filings
15.11.TFFP-Aktie erreicht 52-Wochen-Tief bei 0,40 US-Dollar3Investing.com Deutsch
14.11.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces It Will Wind Down Operations99GlobeNewswire (Europe)FORT WORTH, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has terminated its employees and will wind down its operations. This...
► Artikel lesen
14.11.TFF Pharmaceuticals, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB6SEC Filings
26.09.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals' Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery193GlobeNewswire (Europe)FORT WORTH, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the "Company" or "TFF Pharmaceuticals"), a clinical-stage biopharmaceutical company focused on developing...
► Artikel lesen
11.09.TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment1Seeking Alpha
11.09.TFF Pharmaceuticals partners with Emory University on antiviral tech1Investing.com
11.09.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID1GlobeNewswire (USA)
10.09.TFF Pharmaceuticals reports progress in universal flu vaccine1Investing.com
10.09.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization103GlobeNewswire (Europe)TFF-dry powder HA antigen vaccine candidates induced neutralizing antibody titers in ferrets against H1 and H3 influenza strains Ongoing funded work to assess additional influenza strains FORT WORTH...
► Artikel lesen
14.08.TFF Pharmaceuticals, Inc. - 10-Q, Quarterly Report1SEC Filings
06.08.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection182GlobeNewswire (Europe)Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved >80% of the previous oral trough blood...
► Artikel lesen
06.08.TFF Pharmaceuticals, Inc. - 8-K, Current Report1SEC Filings
29.06.TFF Pharmaceuticals, Inc. - 8-K, Current Report-SEC Filings
26.06.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities2GlobeNewswire (USA)
21.05.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.05.20242.525Xetra NewsboardThe following instruments on Boerse Frankfurt do have their last trading day on 21.05.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.05.2024.ISIN NameCA00379L1067 ABRASILV....
► Artikel lesen
20.05.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing183GlobeNewswire (Europe)FORT WORTH, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the "Company" or "TFF Pharmaceuticals"), a clinical-stage biopharmaceutical company focused on developing...
► Artikel lesen
29.04.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting185GlobeNewswire (Europe)Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplant Rejection at Only One-sixth of the Dose of Oral Tacrolimus and at Two-thirds...
► Artikel lesen
28.03.TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results733GlobeNewswire (Europe)FORT WORTH, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) ("the Company"), a clinical-stage biopharmaceutical company focused on developing and commercializing...
► Artikel lesen
Seite:  1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1